| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Salbutamol sulfate |
Is a |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Albuterol measurement |
Component |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol [inhalation preparations 2] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing salbutamol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Inhaled salbutamol preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol poisoning |
Causative agent (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental salbutamol poisoning |
Causative agent (attribute) |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Intentional salbutamol poisoning |
Causative agent (attribute) |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| intoxication par le salbutamol d'intention indéterminée |
Causative agent (attribute) |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol adverse reaction |
Causative agent (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Allergy to salbutamol |
Causative agent (attribute) |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol overdose |
Causative agent (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Accidental salbutamol overdose |
Causative agent (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional salbutamol overdose |
Causative agent (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| surdose de salbutamol d'intention indéterminée |
Causative agent (attribute) |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol 4mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 4mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 8mg m/r capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 4mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 8mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 2mg/5mL sugar free syrup (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| albutérol 5 mg/50 mL, pour injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Albuterol 250micrograms/5mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 500micrograms/1mL injection (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| albutérol 5 mg/5 mL, perfusion intraveineuse |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 200micrograms/blister disks+disk inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 400micrograms/blister disks+disk inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 200micrograms/blister disks refill (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 400micrograms/blister disks refill |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 100micrograms breath-actuated aerosol inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 200micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 100micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 95micrograms breath-actuated dry powder inhaler (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Albuterol 100micrograms CFC-free breath-actuated aerosol inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 5mg/2.5mL nebulization unit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 100micrograms inhaler (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 2.5mg/2.5mL nebulization unit |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 200micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 400micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 100mg/20mL nebulizer solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol+ipratropium bromide 100micrograms/20micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol+ipratropium bromide 2.5mg/500micrograms nebulization unit (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclomethasone dipropionate+salbutamol 200micrograms/400micrograms inhalation capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclomethasone dipropionate+salbutamol 100micrograms/200micrograms pediatric inhalation capsule (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclomethasone dipropionate+salbutamol 50micrograms/100micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler+spacer |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Sodium cromoglycate+salbutamol 1mg/100micrograms inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol [obstetric] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Beclomethasone dipropionate+salbutamol (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing cromoglicate sodium and salbutamol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Albuterol 200micrograms capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol (as salbutamol sulfate) 830 microgram/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Albuterol sulfate 4mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Albuterol 90mcg/inh aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Albuterol sulphate + ipratropium bromide 103mcg/18mcg aerosol |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Ipratropium bromide 167 microgram/mL and salbutamol (as salbutamol sulfate) 833 microgram/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Product containing salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Albuterol+ipratropium bromide |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 100micrograms breath-actuated dry powder inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol 100micrograms CFC-free inhaler |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Albuterol 0.0417% inhalation solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Accidental salbutamol poisoning |
Causative agent (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Intentional salbutamol poisoning |
Causative agent (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Ipratropium- and salbutamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Beclometasone- and salbutamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Allergy to salbutamol |
Causative agent (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol 4mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol 4mg tablet |
Has basis of strength substance (attribute) |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol 2mg tablet (substance) |
Has basis of strength substance (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol sulfate |
Is modification of (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
| Salbutamol (as salbutamol sulfate) 8 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol (as salbutamol sulfate) 8 mg prolonged-release oral capsule |
Has basis of strength substance (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol (as salbutamol sulfate) 4 mg prolonged-release oral tablet |
Has basis of strength substance (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol (as salbutamol sulfate) 4 mg prolonged-release oral capsule |
Has basis of strength substance (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol 4mg tablet |
Has precise active ingredient |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Cromoglicic acid- and salbutamol-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Salbutamol-containing product in pulmonary dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salbutamol (as salbutamol sulfate) 400 microgram/1 milliliter conventional release oral solution (clinical drug) |
Has basis of strength substance (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salbutamol 200 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
Has precise active ingredient |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salbutamol 200 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
Has basis of strength substance (attribute) |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol (as salbutamol sulfate) 95 microgram/actuation powder for inhalation |
Has basis of strength substance (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salbutamol (as salbutamol sulfate) 100 microgram/1 actuation conventional release powder for inhalation (clinical drug) |
Has basis of strength substance (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol (as salbutamol sulfate) 100 microgram/actuation pressurised suspension for inhalation |
Has basis of strength substance (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salbutamol (as salbutamol sulfate) 500 microgram/1 milliliter conventional release solution for injection ampule |
Has basis of strength substance (attribute) |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salbutamol (as salbutamol sulfate) 5 milligram/50 milliliter conventional release solution for infusion vial |
Has basis of strength substance (attribute) |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salbutamol (as salbutamol sulfate) 5 milligram/5 milliliter conventional release solution for infusion ampule |
Has basis of strength substance (attribute) |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only beclometasone and salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only cromoglicic acid and salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Product containing only ipratropium and salbutamol (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
| Salbutamol only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only salbutamol in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only salbutamol in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing only salbutamol in pulmonary dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salbutamol (as salbutamol sulfate) 100 microgram/1 milliliter conventional release solution for infusion (clinical drug) |
Has basis of strength substance (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol (as salbutamol sulfate) 500 microgram/mL solution for injection |
Has basis of strength substance (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol (as salbutamol sulfate) 4 mg oral tablet |
Has basis of strength substance (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Product containing precisely salbutamol (as salbutamol sulfate) 1 milligram/1 milliliter conventional release solution for inhalation (clinical drug) |
Has basis of strength substance (attribute) |
False |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
| Salbutamol (as salbutamol sulfate) 830 microgram/mL solution for inhalation |
Has basis of strength substance (attribute) |
True |
Salbutamol (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]